COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study

Fei Tang; Iriana S. Hammel; Melissa K. Andrew; Jorge G. Ruiz

doi:10.1016/S2666-7568(22)00166-0

COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study

Fei Tang, Iriana S. Hammel, Melissa K. Andrew, Jorge G. Ruiz

Health Professions

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Original language	English
Pages (from-to)	e589-e598
Journal	The Lancet Healthy Longevity
Volume	3
Issue number	9
DOIs	https://doi.org/10.1016/S2666-7568(22)00166-0
Publication status	Published - Sept 2022

ASJC Scopus Subject Areas

Health(social science)
Geriatrics and Gerontology
Psychiatry and Mental health
Family Practice

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2666-7568(22)00166-0

Fingerprint

Dive into the research topics of 'COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study'. Together they form a unique fingerprint.

Cite this

COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study. / Tang, Fei; Hammel, Iriana S.; Andrew, Melissa K. et al.
In: The Lancet Healthy Longevity, Vol. 3, No. 9, 09.2022, p. e589-e598.

Research output: Contribution to journal › Article › peer-review

@article{7baa6030ff444585bc932544b7b3b583,

title = "COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study",

author = "Fei Tang and Hammel, {Iriana S.} and Andrew, {Melissa K.} and Ruiz, {Jorge G.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license",

year = "2022",

month = sep,

doi = "10.1016/S2666-7568(22)00166-0",

language = "English",

volume = "3",

pages = "e589--e598",

journal = "The Lancet Healthy Longevity",

issn = "2666-7568",

publisher = "Elsevier Ltd.",

number = "9",

}

TY - JOUR

T1 - COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA

T2 - a retrospective cohort study

AU - Tang, Fei

AU - Hammel, Iriana S.

AU - Andrew, Melissa K.

AU - Ruiz, Jorge G.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85137289407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137289407&partnerID=8YFLogxK

U2 - 10.1016/S2666-7568(22)00166-0

DO - 10.1016/S2666-7568(22)00166-0

M3 - Article

AN - SCOPUS:85137289407

SN - 2666-7568

VL - 3

SP - e589-e598

JO - The Lancet Healthy Longevity

JF - The Lancet Healthy Longevity

IS - 9

ER -

COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this